Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Elizabeth R Tucker, Irene Jiménez, Lindi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Blood
|
June 24, 2020
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
Nina Prokoph, Nicola A Probst, Liam C Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Andrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
NPJ Precision Oncology
|
January 10, 2026
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology
Marlinde C Schoonbeek, Pierre Gestraud, Lindy Vernooij, et al.
EMBO Molecular Medicine
|
December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncology
Agathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
British Journal of Cancer
|
June 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma
Joseph S Baxter, Claudia Montiel Equihua, Jan J Molenaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Elizabeth R Tucker, Irene Jiménez, Lindi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Blood
|
June 24, 2020
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
Nina Prokoph, Nicola A Probst, Liam C Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Andrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
NPJ Precision Oncology
|
January 10, 2026
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology
Marlinde C Schoonbeek, Pierre Gestraud, Lindy Vernooij, et al.
EMBO Molecular Medicine
|
December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncology
Agathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
British Journal of Cancer
|
June 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma
Joseph S Baxter, Claudia Montiel Equihua, Jan J Molenaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Page
of 18